TIFFANY DIAZ: Open Payments
NPI 1801572664 · BOERNE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 39 payments from 13 companies in 2025. Trend: 2023 $120 · 2024 $650 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $155 |
| Daiichi Sankyo Inc. | 9 | $139 |
| Calliditas Therapeutics US Inc. | 3 | $88 |
| OPKO Pharmaceuticals, LLC | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| KYOWA KIRIN, INC. | 2 | $51 |
| GENZYME CORPORATION | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $48 |
| Amgen Inc. | 1 | $29 |
| Pharmacosmos Therapeutics Inc. | 1 | $22 |
Products named: FARXIGA, INJECTAFER, TARPEYO, RAYALDEE, JYNARQUE, CRYSVITA, FABRAZYME, SHINGRIX.
Industry payments across TX — which companies pay providers there.
